Echo Street Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,202
Closed -$249K 692
2022
Q2
$249K Sell
4,202
-3,951
-48% -$324K ﹤0.01% 465
2022
Q1
$948K Buy
+8,153
New +$952K 0.01% 244
2021
Q3
Sell
-4,217
Closed -$411K 751
2021
Q2
$411K Buy
+4,217
New +$376K ﹤0.01% 419
2020
Q3
Sell
-5,443
Closed -$538K 345
2020
Q2
$538K Buy
+5,443
New +$434K 0.01% 350

Other funds holding TNDM

Echo Street Capital Management's TNDM Position: Q3 2022 in Review

Echo Street Capital Management sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 4,202 shares — an estimated $249K sold.

Echo Street Capital Management first reported a position in TNDM in Q2 2020 and held it in 4 quarters. The position peaked at $948K in Q1 2022. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

  • Echo Street Capital Management reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
  • Echo Street Capital Management sold 4,202 Tandem Diabetes Care shares in Q3 2022, an estimated $249K.
  • Echo Street Capital Management first reported a position in Tandem Diabetes Care in Q2 2020 and held it in 4 quarters.
  • Echo Street Capital Management's Tandem Diabetes Care position peaked at $948K in Q1 2022.
  • 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Echo Street Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.